Search

everythinglearnresearchcommunity

for

Search:↓

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Early recognition and a multidisciplinary approach are crucial for effectively managing complex autoimmune conditions like SLE with CAPS and AHA.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Chemotherapy caused a woman's permanent hair loss and early menopause.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Cancer treatments often cause skin, nail, and hair problems.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.